The data on the prognostic significance of low volume metastases in lymph nodes (LN) are inconsistent. The aim of this study was to retrospectively analyze the outcome of a large group of patients treated with sentinel lymph node (SLN) biopsy at a single referral center. Patients with cervical cancer, stage T1a-T2b, common tumor types, negative LN on preoperative staging, treated by primary surgery between 01/2007 and 12/2016, with at least unilateral SLN detection were included. Patients with abandoned radical surgery due to intraoperative SLN positivity detected by frozen section were excluded. All SLNs were postoperatively processed by an intensive protocol for pathological ultrastaging. Altogether, 226 patients were analyzed. Positive LN were detected in 38 (17%) cases; macrometastases (MAC), micrometastases (MIC), isolated tumor cells (ITC) in 14, 16, and 8 patients. With the median follow-up of 65 months, 22 recurrences occurred. Disease-free survival (DFS) reached 90% in the whole group, 93% in LN-negative cases, 89% in cases with MAC, 69% with MIC, and 87% with ITC. The presence of MIC in SLN was associated with significantly decreased DFS and OS. Patients with MIC and MAC should be managed similarly, and SLN ultrastaging should become an integral part of the management of patients with early-stage cervical cancer.

Department of Pathology 1st Faculty of Medicine Charles University Prague and General University Hospital Prague 128 00 Prague Czech Republic

Department of Radiology 1st Faculty of Medicine Charles University Prague and General University Hospital Prague 128 00 Prague Czech Republic

Gynecologic Oncology Center Department of Obstetrics and Gynecology 1st Faculty of Medicine Charles University Prague and General University Hospital Prague 128 00 Prague Czech Republic

Institute of Biostatistics and Analyses; Faculty of Medicine Masaryk University 625 00 Brno Czech Republic

Institute of Health Information and Statistics of the Czech Republic 128 01 Prague Czech Republic

Zobrazit více v PubMed

Cibula D., Abu-Rustum N.R., Dusek L., Zikán M., Zaal A., Sevcik L., Kenter G.G., Querleu D., Jach R., Bats A.S., et al. Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. Gynecol. Oncol. 2012;124:496–501. doi: 10.1016/j.ygyno.2011.11.037. PubMed DOI

Rob L., Charvat M., Robova H., Strnad P., Pluta M., Halaska M., Hrehorcak M., Schlegerova D., Taborska K. Sentinel lymph node identification (SLNI) in the management of conservative surgery in early cervical cancer: Is it acceptable? Gynecol. Oncol. 2005;99:S147–S148. doi: 10.1016/j.ygyno.2005.07.068. PubMed DOI

Wydra D., Sawicki S., Wojtylak S., Bandurski T., Emerich J. Sentinel node identification in cervical cancer patients undergoing transperitoneal radical hysterectomy: A study of 100 cases. Int. J. Gynecol. Cancer. 2006;16:649–654. doi: 10.1111/j.1525-1438.2006.00402.x. PubMed DOI

Darlin L., Persson J., Bossmar T., Lindahl B., Kannisto P., Måsbäck A., Borgfeldt C. The sentinel node concept in early cervical cancer performs well in tumors smaller than 2 cm. Gynecol. Oncol. 2010;117:266–269. doi: 10.1016/j.ygyno.2010.01.035. PubMed DOI

Altgassen C., Hertel H., Brandstädt A., Köhler C., Dürst M., Schneider A. Multicenter Validation Study of the Sentinel Lymph Node Concept in Cervical Cancer: AGO Study Group. J. Clin. Oncol. 2008;26:2943–2951. doi: 10.1200/JCO.2007.13.8933. PubMed DOI

Marnitz S., Köhler C., Bongardt S., Braig U., Hertel H., Schneider A. Topographic distribution of sentinel lymph nodes in patients with cervical cancer. Gynecol. Oncol. 2006;103:35–44. doi: 10.1016/j.ygyno.2006.01.061. PubMed DOI

Cibula D., Kuzel D., Slama J., Fischerova D., Dundr P., Freitag P., Zikán M., Pavlista D., Tomancova V. Sentinel node (SLN) biopsy in the management of locally advanced cervical cancer. Gynecol. Oncol. 2009;115:46–50. doi: 10.1016/j.ygyno.2009.06.017. PubMed DOI

Du X.L., Sheng X.G., Jiang T., Li Q.S., Yu H., Pan C.X., Lu C.H., Wang C., Song Q.Q. Sentinel lymph node biopsy as guidance for radical trachelectomy in young patients with early stage cervical cancer. BMC Cancer. 2011;11 doi: 10.1186/1471-2407-11-157. PubMed DOI PMC

Abu-Rustum N., Sonoda Y. Fertility-Sparing Surgery in Early-Stage Cervical Cancer: Indications and Applications. J. Natl. Compr. Cancer Netw. 2010;8:1435–1438. doi: 10.6004/jnccn.2010.0107. PubMed DOI

Cibula D., SlÁMa J., SvÁRovskÝ J., Fischerova D., Freitag P., ZikÁN M., PinkavovÁ I., Pavlista D., Dundr P., Hill M. Abdominal Radical Trachelectomy in Fertility-Sparing Treatment of Early-Stage Cervical Cancer. Int. J. Gynecol. Cancer. 2009;19:1407–1411. doi: 10.1111/IGC.0b013e3181b9549a. PubMed DOI

Euscher E., Malpica A., Atkinson E., Levenback C., Frumovitz M., Deavers M. Ultrastaging Improves Detection of Metastases in Sentinel Lymph Nodes of Uterine Cervix Squamous Cell Carcinoma. Am. J. Surg Pathol. 2008;32:1336–1343. doi: 10.1097/PAS.0b013e31816ecfe4. PubMed DOI

Lentz S., Muderspach L., Felix J., Ye W., Groshen S., Amezcua C. Identification of Micrometastases in Histologically Negative Lymph Nodes of Early-Stage Cervical Cancer Patients. Obstet. Gynecol. 2004;103:1204–1210. doi: 10.1097/01.AOG.0000125869.78251.5e. PubMed DOI

Daraï E., Rouzier R., Ballester M., Barranger E., Coutant C. Sentinel lymph node biopsy in gynaecological cancers: The importance of micrometastases in cervical cancer. Surg. Oncol. 2008;17:227–235. doi: 10.1016/j.suronc.2008.04.002. PubMed DOI

Horn L., Hentschel B., Fischer U., Peter D., Bilek K. Detection of micrometastases in pelvic lymph nodes in patients with carcinoma of the cervix uteri using step sectioning: Frequency, topographic distribution and prognostic impact. Gynecol. Oncol. 2008;111:276–281. doi: 10.1016/j.ygyno.2008.07.017. PubMed DOI

Marchiolè P., Buénerd A., Benchaib M., Nezhat K., Dargent D., Mathevet P. Clinical significance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer: A retrospective case-control surgico-pathological study. Gynecol. Oncol. 2005;97:727–732. doi: 10.1016/j.ygyno.2005.01.004. PubMed DOI

Juretzka M., Jensen K., Longacre T., Teng N., Husain A. Detection of pelvic lymph node micrometastasis in stage IA2–IB2 cervical cancer by immunohistochemical analysis. Gynecol. Oncol. 2004;93:107–111. doi: 10.1016/j.ygyno.2003.11.033. PubMed DOI

Fregnani J., Latorre M., Novik P., Lopes A., Soares F. Assessment of pelvic lymph node micrometastatic disease in stages IB and IIA of carcinoma of the uterine cervix. Int. J. Gynecol. Cancer. 2006;16:1188–1194. doi: 10.1136/ijgc-00009577-200605000-00037. PubMed DOI

Stany M.P., Stone P.J., Felix J.C., Amezcua C.A., Groshen S., Ye W., Kyser K.L., Howard R.S., Zahn C.M., Muderspach L.I., et al. Lymph Node Micrometastases in Early-Stage Cervical Cancer are Not Predictive of Survival. Int. J. Gynecol. Pathol. 2015;34:379–384. doi: 10.1097/PGP.0000000000000188. PubMed DOI PMC

Colturato L., Signorini Filho R., Fernandes R., Gebrim L., Oliani A. Lymph node micrometastases in initial stage cervical cancer and tumoral recurrence. Int. J. Gynecol. Obstet. 2015;133:69–75. doi: 10.1016/j.ijgo.2015.08.019. PubMed DOI

Guani B., Dorez M., Magaud L., Buenerd A., Lecuru F., Mathevet P. Impact of micrometastasis or isolated tumor cells on recurrence and survival in patients with early cervical cancer: SENTICOL Trial. Int. J. Gynecol. Cancer. 2019;29:447–452. doi: 10.1136/ijgc-2018-000089. PubMed DOI

Bizzarri N., Anchora L.P., Zannoni G.F., Santoro A., Valente M., Inzani F., Gallotta V., Conte C., Chiantera V., Fanfani F., et al. Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer. Int. J. Gynecol. Cancer. 2020;30:364–371. doi: 10.1136/ijgc-2019-000939. PubMed DOI

Dostálek L., Zikan M., Fischerova D., Kocian R., Germanova A., Frühauf F., Dusek L., Slama J., Dundr P., Nemejcova K., et al. SLN biopsy in cervical cancer patients with tumors larger than 2 cm and 4 cm. Gynecol. Oncol. 2018;148:456–460. doi: 10.1016/j.ygyno.2018.01.001. PubMed DOI

Diaz J.P., Gemignani M.L., Pandit-Taskar N., Park K.J., Murray M.P., Chi D.S., Sonoda Y., Barakat R.R., Abu-Rustum N.R. Sentinel lymph node biopsy in the management of early-stage cervical carcinoma. Gynecol. Oncol. 2011;120:347–352. doi: 10.1016/j.ygyno.2010.12.334. PubMed DOI PMC

Salvo G., Ramirez P.T., Levenback C.F., Munsell M.F., Euscher E.D., Soliman P.T., Frumovitz M. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol. Oncol. 2017;145:96–101. doi: 10.1016/j.ygyno.2017.02.005. PubMed DOI PMC

Van Trappen P.O., Gyselman V.G., Lowe D.G., Ryan A., Oram D.H., Bosze P., Weekes A.R., Shepherd J.H., Dorudi S., Bustin S.A., et al. Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet. 2001;357:15–20. doi: 10.1016/S0140-6736(00)03566-2. PubMed DOI

Bats A.S., Mathevet P., Buenerd A., Orliaguet I., Mery E., Zerdoud S., Le Frère-Belda M.A., Froissart M., Querleu D., Martinez A., et al. The Sentinel Node Technique Detects Unexpected Drainage Pathways and Allows Nodal Ultrastaging in Early Cervical Cancer: Insights from the Multicenter Prospective SENTICOL Study. Ann. Surg. Oncol. 2012;20:413–422. doi: 10.1245/s10434-012-2597-7. PubMed DOI

Dundr P., Cibula D., Němejcová K., Tichá I., Bártů M., Jakša R. Pathologic Protocols for Sentinel Lymph Nodes Ultrastaging in Cervical Cancer. Arch. Pathol. Lab. Med. 2019 doi: 10.5858/arpa.2019-0249-RA. PubMed DOI

Lécuru F., Mathevet P., Querleu D., Leblanc E., Morice P., Daraï E., Marret H., Magaud L., Gillaizeau F., Chatellier G., et al. Bilateral Negative Sentinel Nodes Accurately Predict Absence of Lymph Node Metastasis in Early Cervical Cancer: Results of the SENTICOL Study. J. Clin. Oncol. 2011;29:1686–1691. doi: 10.1200/JCO.2010.32.0432. PubMed DOI

Rob L., Robova H., Halaska M., Hruda M., Skapa P. Current status of sentinel lymph node mapping in the management of cervical cancer. Expert Rev. Anticancer Ther. 2013;13:861–870. doi: 10.1586/14737140.2013.811147. PubMed DOI

Bats A.S., Buénerd A., Querleu D., Leblanc E., Daraï E., Morice P., Marret H., Gillaizeau F., Mathevet P., Lécuru F. Diagnostic value of intraoperative examination of sentinel lymph node in early cervical cancer: A prospective, multicenter study. Gynecol. Oncol. 2011;123:230–235. doi: 10.1016/j.ygyno.2011.08.010. PubMed DOI

Martínez A., Mery E., Filleron T., Boileau L., Ferron G., Querleu D. Accuracy of intraoperative pathological examination of SLN in cervical cancer. Gynecol. Oncol. 2013;130:525–529. doi: 10.1016/j.ygyno.2013.01.023. PubMed DOI

Delgado G., Bundy B., Zaino R., Sevin B., Creasman W., Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol. Oncol. 1990;38:352–357. doi: 10.1016/0090-8258(90)90072-S. PubMed DOI

Hellebrekers B.W., Zwinderman A.H., Kenter G.G., Peters A.A., Snijders-Keilholz A., Graziosi G.C., Fleuren G.J., Trimbos J.B. Surgically-treated early cervical cancer: Prognostic factors and the significance of depth of tumor invasion. Int. J. Gynecol. Cancer. 1999;9:212–219. doi: 10.1046/j.1525-1438.1999.99023.x. PubMed DOI

Ramirez P., Frumovitz M., Pareja R. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer. N. Engl. J. Med. 2018;379:1895–1904. doi: 10.1056/NEJMoa1806395. PubMed DOI

Kong T.W., Chang S.J., Piao X., Paek J., Lee Y., Lee E.J., Chun M., Ryu H.S. Patterns of recurrence and survival after abdominal versus laparoscopic/robotic radical hysterectomy in patients with early cervical cancer. J. Obstet. Gynaecol. Res. 2015;42:77–86. doi: 10.1111/jog.12840. PubMed DOI

Cibula D., McCluggage W. Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions. Gynecol. Oncol. 2019;152:202–207. doi: 10.1016/j.ygyno.2018.10.007. PubMed DOI

Brar H., Hogen L., Covens A. Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer. Cancer. 2017;123:1751–1759. doi: 10.1002/cncr.30509. PubMed DOI

Cibula D., Abu-Rustum N. Pelvic lymphadenectomy in cervical cancer—Surgical anatomy and proposal for a new classification system. Gynecol. Oncol. 2010;116:33–37. doi: 10.1016/j.ygyno.2009.09.003. PubMed DOI

Querleu D., Cibula D., Abu-Rustum N. 2017 Update on the Querleu–Morrow Classification of Radical Hysterectomy. Ann. Surg. Oncol. 2017;24:3406–3412. doi: 10.1245/s10434-017-6031-z. PubMed DOI PMC

Querleu D., Morrow C. Classification of radical hysterectomy. Lancet Oncol. 2008;9:297–303. doi: 10.1016/S1470-2045(08)70074-3. PubMed DOI

Cibula D., Pötter R., Planchamp F., Avall-Lundqvist E., Fischerova D., Meder C.H., Köhler C., Landoni F., Lax S., Lindegaard J.C., et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer. Virchows Archiv. 2018;472:919–936. doi: 10.1007/s00428-018-2362-9. PubMed DOI

MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?

Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical implication in patients with cervical cancer: Subgroup analysis of the SCCAN project